World Drug Safety Congress Europe 2018


"Very wide scope of PV related subjects"

Global Head Pharmacovigilance and Drug Safety, Roche


"Nice mix of sponsors, regulators and vendors"

Executive Medical Director, Pharmacovigilance and Patient Safety, AbbVie


"The congress is quite ahead in terms of seminar topics with vision from world class leaders!"

Global Safety Lead Scientist, Grünenthal GmbH


"Excelent program with world-class speakers, content is always highly relevant".

Co-chair, Pharmacovigilance Working Group, Medicines for Europe


"The excellent program covering a wide range of topics and perspectives within drug safety, and great networking opportunities"

Chief Medical Officer, member of PRAC at EMA, Danish Medicines Agency


"Very high quality of speakers and the program covers perfectly the different aspects and requirements of PV and safety in our current environment."

Safety Science Senior Group Director, Roche


"It was a great platform for information sharing and gathering new ideas. Speakers were excellent."

TA Med Evaluation Lead, CSL


"High quality of presentations / Speakers and a good mix of topics."

Vice President Safety & Risk Management, PRA Health Sciences




Past Testimonials


"Excellent range of presenters on largely relevant and up to the minute topics and consequently a great audience."

Head of Development Consulting, Pope Woodhead & Associates Ltd


"Well organized event with an excellent agenda and scientific topics covered. Quality in the presentations and speakers scientific level. A good framework for networking and scientific relationship."

Ferrer Internacional, S.A., Spain


"Great content and very well attended by industry experts."

President, AgilePV


"Hot topics, great networking opportunities, and the possibility to share information and best practices, and shape the future of PV."

Global Scientific Excellence Lead, Safety Risk Management


"Great presentations, lots of discussions about available technologies, future directions, wide representation from industry and regulators."

Deputy LSR, Roche


"Superb range of speakers and topics and great to have a truly global perspective. Excellent venue."

Head of regulatory and safety policy, Association of the British Pharmaceutical Industry


"Well organised event with key industry personnel in attendance and speaking. The one-to-one meeting organisation service provided worked really well."

Business Development Director, MyMeds&Me


"All presentations are excellent; the mix of topics reflects the major discussion points in the industry the event was very well organized."

Vice President Safety & Risk Management, PRA Health Sciences


"Very well organized, good speakers, covered all current relevant topics."

Global Head, Drug Safety and Risk Management, Lupin Ltd


"Impressed by the organisation of the event, and the relevance of its content."

Director, Patient Safety, AstraZeneca


“I do feel that the event was very successful. I received many positive comments about the topics – how interesting / valuable they were - the high quality of the speakers, and the overall good organization by Terrapin. It was the best PV event that I have been involved with.”

Chief Safety Officer, CSL Behring


“The roundtables were one of the best things about the conference. They were a great opportunity to compare notes on how certain difficult tasks and interpretations of the regulations are handled.”

Associate Director Risk Management, AstraZeneca


“The agenda you have provided is very interesting and very different to the usual PV meeting agendas. It is very much technology and new therapies oriented and at first glance not mainstream, but this may be exactly what differentiates your conference from the others.”

Head PV Intelligence & Deputy EU QPPV, Boehringer Ingelheim


“The program looks very promising. In the Danish Agency, we are right now working on our future data strategy and discussing how we can welcome new and upcoming technologies both in pharmacovigilance and other regulatory areas.”

Chief Advisor, Danish Medicines Agency


“It looks like a packed agenda. With lots of interesting topics.”

Therapy Area Safety Lead Ophthalmology, Drug Safety and Epidemiology, Novartis


“Good list of speakers, including regulators. Diverse set of topics, very current”

Head of Drug Safety and Pharmacovigilance International and EU QPPV, Amicus Therapeutics UK


"Superb range of speakers and topics and great to have a truly global perspective. Excellent venue."

Head of Regulatory and Safety Policy, Association of the British Pharmaceutical Industry


"Very well organized, good speakers, covered all current relevant topics."

Global Head, Drug Safety and Risk Management, Lupin


    "The congress was really great, the information, especially the round table discussions. I really enjoyed this congress and already recommended it to a friend."

LPVM, Boehringer Ingelheim (Schweiz) GmbH


"Great presentations, great networking, a good place to have pharmacovigilanve overall exposure, problems, common themes."

Vice President - Patient Safety, AstraZeneca





Get Involved At World Drug Safety Congress


To Sponsor Or Exhibit

Edmond Rama
+44 20 7092 1052




To Speak

Anastasia Beretsos
+44 20 7092 1070




To Register

Tayyab Abbasi
+44 20 7092 1210